Jan. 15 at 7:30 AM
$CRWV
Hard to ignore this one heading into 2026.
Backed by
$NVDA as its largest position, the growth trajectory is aggressive and margins are tightening fast. Losses are shrinking, profitability is within sight, and the story is starting to shift from “potential” to “execution.” @scholar9
If momentum continues and the market rewards growth + operating leverage, I see a path toward much higher prices. My upside target remains
$310.
Not a straight line, but the risk/reward here looks compelling for patient bulls.